Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)

Clinical trial NCT06294236 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06294236
Sponsor: Sana Biotechnology
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Lupus Erythematosus Systemic Lupus Erythematosus SLE (Systemic Lupus)Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Granulomatous Polyangiitis Microscopic Polyangiitis

Start date: 2024-04-29
Primary completion: 2027-12-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.